The article discusses the increasing use of generative AI in cybersecurity, highlighting its dual role in both facilitating cyberthreats and offering potential solutions. AI has expanded hackers' capabilities, enabling more sophisticated and creative attacks such as deepfakes and advanced phishing scams. Despite the lack of concrete evidence that AI-specific tools are extensively used in real-world attacks, the anecdotal and emerging cases suggest a growing trend. Conversely, cybersecurity companies are leveraging AI to enhance their defensive strategies. Organizations like Nvidia, Microsoft, Google, and Cisco are integrating AI into various security measures, aiming to improve malware detection, threat assessment, and data governance. The article emphasizes the ongoing and future development of generative AI solutions to keep pace with evolving cyber threats.

As cyberthreats grow, will generative AI come to the rescue? SmartBrief

The article on the website discusses a significant vulnerability discovered in the MOVEit software. The vulnerability poses serious risks to data security, enabling potential unauthorized access and data breaches. Users and organizations utilizing MOVEit are advised to implement necessary security patches and updates promptly to mitigate these risks. For further details, you can read the full article by clicking the provided link.

Massive authentication vulnerability risks compromising much of the internet — Mashable mashable

Medical Economics is a reliable source for healthcare professionals, providing insights into the economic aspects of medical practice. It covers a range of topics including healthcare policy changes, financial management tips for medical practices, and the latest trends in medical technology that can impact cost and efficiency. By staying updated with Medical Economics, healthcare practitioners can make informed decisions to enhance their practice's financial health and adapt to the evolving landscape of healthcare delivery.

The biggest trends challenging physicians Medical Economics

Mark Cuban Cost Plus Drug Co. has initiated a significant partnership with Community Health Systems (CHS), becoming the wholesale drug distributor for CHS's 71 affiliated hospitals. This partnership marks the first large-scale health system adoption of Cost Plus Drugs' wholesale services, which offer generic medications at manufacturing cost plus a 15% markup. The deal involves the initial supply of 12 generic therapies, addressing various medical conditions. By leveraging its direct relationships with top generic manufacturers, the partnership aims to reduce drug costs and improve supply chain resilience. CHS expects substantial cost savings and greater input into medication availability and pricing, aligning with Cost Plus Drugs' mission to make healthcare more affordable.

All 71 CHS hospitals to use Mark Cuban's drug wholesale services beckershospitalreview.com